TUDOR INVESTMENT CORP ET AL - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 194 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$105,151
+8956.9%
13,533
-87.2%
0.00%
-94.4%
Q1 2023$1,161
+541.4%
105,952
+153.2%
0.02%
+350.0%
Q4 2022$181
-100.0%
41,839
-32.9%
0.00%
-75.0%
Q2 2022$627,000
-12.1%
62,369
+100.1%
0.02%
+33.3%
Q4 2021$713,000
+101.4%
31,176
+94.8%
0.01%
+100.0%
Q3 2021$354,00016,0000.01%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 503,248$6,535,00010.30%
Prosight Management, LP 360,834$4,685,0003.84%
Healthcare Value Capital, LLC 100,000$1,299,0002.89%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,748,208$22,700,0002.32%
DG Capital Management, LLC 591,154$7,676,0001.83%
NEA Management Company, LLC 5,172,683$67,193,0001.51%
Altium Capital Management LP 408,908$5,310,0001.47%
IRONWOOD INVESTMENT MANAGEMENT LLC 170,316$2,212,0001.17%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 298,500$3,875,0001.02%
KNOTT DAVID M 154,840$2,011,0000.86%
View complete list of AURINIA PHARMACEUTICALS INC shareholders